Pharmaceutical Regulatory Affairs: Open Access (PRAO is a broad-based journal founded on two key tenets: To publish the most exciting researches with respect to the subjects on Pharmaceutical Regulatory Affairs : Secondly, to provide a rapid turn-around time possible for reviewing and publishing and to disseminate the articles freely for research, teaching and reference purposes.
It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals and researchers and professional bodies and institutions.
All works published by OMICS International are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. PRAO strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. PRAO will keep up-to- date with latest advances in the field of Pharmaceutical Regulatory Affairs. Abstracts and full texts (HTML, PDF and XML format) of all articles published by PROA are freely accessible to everyone immediately after publication. PROA supports the Bethesda Statement on Open Access Publishing.